155 related articles for article (PubMed ID: 1672588)
1. Intermittent vs maintenance medication in schizophrenia. Two-year results.
Herz MI; Glazer WM; Mostert MA; Sheard MA; Szymanski HV; Hafez H; Mirza M; Vana J
Arch Gen Psychiatry; 1991 Apr; 48(4):333-9. PubMed ID: 1672588
[TBL] [Abstract][Full Text] [Related]
2. Standard olanzapine versus placebo and ineffective-dose olanzapine in the maintenance treatment of schizophrenia.
Dellva MA; Tran P; Tollefson GD; Wentley AL; Beasley CM
Psychiatr Serv; 1997 Dec; 48(12):1571-7. PubMed ID: 9406266
[TBL] [Abstract][Full Text] [Related]
3. Brief intermittent neuroleptic prophylaxis for selected schizophrenic out-patients.
McClelland HA; Harrison G; Soni SD
Br J Psychiatry; 1989 Nov; 155():702-6. PubMed ID: 2575424
[No Abstract] [Full Text] [Related]
4. A program for relapse prevention in schizophrenia: a controlled study.
Herz MI; Lamberti JS; Mintz J; Scott R; O'Dell SP; McCartan L; Nix G
Arch Gen Psychiatry; 2000 Mar; 57(3):277-83. PubMed ID: 10711914
[TBL] [Abstract][Full Text] [Related]
5. Intermittent medication for stable schizophrenic outpatients: an alternative to maintenance medication.
Herz MI; Szymanski HV; Simon JC
Am J Psychiatry; 1982 Jul; 139(7):918-22. PubMed ID: 6124133
[TBL] [Abstract][Full Text] [Related]
6. Maintenance therapy and the natural course of schizophrenia.
Davis JM
J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):18-21. PubMed ID: 2865252
[TBL] [Abstract][Full Text] [Related]
7. Continuous versus targeted medication in schizophrenic outpatients: outcome results.
Carpenter WT; Hanlon TE; Heinrichs DW; Summerfelt AT; Kirkpatrick B; Levine J; Buchanan RW
Am J Psychiatry; 1990 Sep; 147(9):1138-48. PubMed ID: 1974743
[TBL] [Abstract][Full Text] [Related]
8. Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia.
Marder SR; Wirshing WC; Van Putten T; Mintz J; McKenzie J; Johnston-Cronk K; Lebell M; Liberman RP
Arch Gen Psychiatry; 1994 Apr; 51(4):280-7. PubMed ID: 8161288
[TBL] [Abstract][Full Text] [Related]
9. Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year.
Jolley AG; Hirsch SR; McRink A; Manchanda R
BMJ; 1989 Apr; 298(6679):985-90. PubMed ID: 2567190
[TBL] [Abstract][Full Text] [Related]
10. [Detection of early warning signs in schizophrenic patients. Possible applications in prevention of recurrence].
Wiedemann G; Hahlweg K; Hank G; Feinstein E; Müller U; Dose M
Nervenarzt; 1994 Jul; 65(7):438-43. PubMed ID: 7800087
[TBL] [Abstract][Full Text] [Related]
11. First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies.
Gaebel W; Jänner M; Frommann N; Pietzcker A; Köpcke W; Linden M; Müller P; Müller-Spahn F; Tegeler J
Schizophr Res; 2002 Jan; 53(1-2):145-59. PubMed ID: 11728846
[TBL] [Abstract][Full Text] [Related]
12. "Extended" antipsychotic dosing in the maintenance treatment of schizophrenia: a double-blind, placebo-controlled trial.
Remington G; Seeman P; Feingold A; Mann S; Shammi C; Kapur S
J Clin Psychiatry; 2011 Aug; 72(8):1042-8. PubMed ID: 20868639
[TBL] [Abstract][Full Text] [Related]
13. Treating prodromal episodes to prevent relapse in schizophrenia.
Herz MI; Glazer W; Mirza M; Mostert M; Hafez H
Br J Psychiatry Suppl; 1989 Jul; (5):123-7. PubMed ID: 2574984
[No Abstract] [Full Text] [Related]
14. Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical and social outcome at two years.
Jolley AG; Hirsch SR; Morrison E; McRink A; Wilson L
BMJ; 1990 Oct; 301(6756):837-42. PubMed ID: 2282421
[TBL] [Abstract][Full Text] [Related]
15. Discontinuation of neuroleptic medication in older, outpatient schizophrenics. A placebo-controlled, double-blind trial.
Ruskin PE; Nyman G
J Nerv Ment Dis; 1991 Apr; 179(4):212-4. PubMed ID: 1672547
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia.
Bodkin JA; Siris SG; Bermanzohn PC; Hennen J; Cole JO
Am J Psychiatry; 2005 Feb; 162(2):388-90. PubMed ID: 15677608
[TBL] [Abstract][Full Text] [Related]
17. Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia.
Gaebel W; Riesbeck M; Wölwer W; Klimke A; Eickhoff M; von Wilmsdorff M; Lemke M; Heuser I; Maier W; Huff W; Schmitt A; Sauer H; Riedel M; Klingberg S; Köpcke W; Ohmann C; Möller HJ;
J Clin Psychiatry; 2011 Feb; 72(2):205-18. PubMed ID: 20673559
[TBL] [Abstract][Full Text] [Related]
18. A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients.
Inderbitzin LB; Lewine RR; Scheller-Gilkey G; Swofford CD; Egan GJ; Gloersen BA; Vidanagama BP; Waternaux C
Am J Psychiatry; 1994 Dec; 151(12):1753-9. PubMed ID: 7977881
[TBL] [Abstract][Full Text] [Related]
19. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
[TBL] [Abstract][Full Text] [Related]
20. Carbamazepine maintenance treatment in outpatient schizophrenics.
Carpenter WT; Kurz R; Kirkpatrick B; Hanlon TE; Summerfelt AT; Buchanan RW; Waltrip RW; Breier A
Arch Gen Psychiatry; 1991 Jan; 48(1):69-72. PubMed ID: 1670617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]